MN HF4

Prohibits drug manufacturers and wholesale drug distributors from charging unconscionable prices for essential prescription drugs in Minnesota, defined as drugs costing more than $80 for a 30-day supply or full course of treatment that are covered by medical assistance or Medicare Part D.

Requires the Board of Pharmacy, commissioner of human services, and health plan companies to notify the attorney general of any essential prescription drug price increase of 15 percent or more during a one-year period.

Authorizes the attorney general to investigate and bring enforcement actions against drug manufacturers and wholesalers for violations, requiring a meeting with the manufacturer or distributor before legal action can be filed.

Establishes Board of Pharmacy civil penalties up to $25,000 per violation of the unconscionable pricing prohibition and provides a private right of action for injured persons.

Appropriates $46,000 in fiscal year 2021 to the commissioner of human services and $427,000 to the attorney general for implementation and enforcement, with federal participation of $15,000-$17,000 annually.